Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 52.50
-1.00 (-1.87%)
Feb 17, 2025, 8:00 AM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 32.06 million as of February 21, 2025. Its market cap has decreased by -27.16% in one year.
Market Cap
32.06M
Enterprise Value
37.05M
Revenue
25.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.50
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 32.06M, a decrease of -21.82%. That is a compound annual growth rate of -1.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |